Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform ...

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 ...

Law Offices of Howard G. Smith announces an investigation on behalf of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN) investors ...

The success of the Fund, BPI, Boston Pizza Canada Limited Partnership ("BP Canada LP"), and Boston Pizza restaurants, including the amount of Franchise Sales, Royalty Income, Distribution Income, and ...

Final voting results on all matters voted on at the meeting have been filed on SEDAR+ at www.sedarplus.ca.

A non-GAAP financial measure which does not have a standardized meaning under the Accounting Standards; see "Specified Financial Measures" section of this press release. In Cold Lake, production of ...

Preliminary Economic Assessment underway, aiming to demonstrate scale and economic upside of the Cacharposa copper-gold deposit and will include results from recent c.2,600m of drilling as well as ...

STOCKHOLM, May 15, 2025 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) plans to ramp up its commitment to Japan's connectivity ecosystem through R&D investment that will initially see up to 300 high-skilled ...

Metallurgical program ongoing - Aimed at refining orebody domains and developing a more comprehensive, de-risked metallurgical model reflected in an updated Mineral Resource Estimate ("MRE") and ...

2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance ...

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce its financial and ...

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder ...